| __timestamp | Lantheus Holdings, Inc. | Veracyte, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 13673000 | 9804000 |
| Thursday, January 1, 2015 | 14358000 | 12796000 |
| Friday, January 1, 2016 | 12203000 | 15324000 |
| Sunday, January 1, 2017 | 18125000 | 13881000 |
| Monday, January 1, 2018 | 17071000 | 14820000 |
| Tuesday, January 1, 2019 | 20018000 | 14851000 |
| Wednesday, January 1, 2020 | 32788000 | 17204000 |
| Friday, January 1, 2021 | 44966000 | 29843000 |
| Saturday, January 1, 2022 | 311681000 | 40603000 |
| Sunday, January 1, 2023 | 77707000 | 57305000 |
Igniting the spark of knowledge
In the competitive landscape of biotechnology, research and development (R&D) spending is a critical indicator of innovation and future growth. Over the past decade, Lantheus Holdings, Inc. and Veracyte, Inc. have demonstrated distinct trajectories in their R&D investments.
From 2014 to 2023, Lantheus Holdings, Inc. increased its R&D budget by over 460%, peaking in 2022 with a staggering 311 million USD, a testament to its commitment to innovation. In contrast, Veracyte, Inc. showed a steady yet modest growth of approximately 485% in the same period, reaching its highest R&D expenditure in 2023.
This divergence highlights Lantheus's aggressive strategy in recent years, particularly in 2022, while Veracyte maintains a consistent upward trend. These insights underscore the dynamic nature of R&D investments in the biotech sector, reflecting each company's strategic priorities and market positioning.
Research and Development Expenses Breakdown: argenx SE vs Lantheus Holdings, Inc.
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and Veracyte, Inc.
Research and Development Expenses Breakdown: Genmab A/S vs Lantheus Holdings, Inc.
R&D Insights: How Bio-Techne Corporation and Lantheus Holdings, Inc. Allocate Funds
Research and Development Expenses Breakdown: Blueprint Medicines Corporation vs Veracyte, Inc.
Research and Development Investment: Lantheus Holdings, Inc. vs Viking Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Lantheus Holdings, Inc. and ADMA Biologics, Inc.
R&D Insights: How Lantheus Holdings, Inc. and Soleno Therapeutics, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Lantheus Holdings, Inc. and Mesoblast Limited
Research and Development Expenses Breakdown: Lantheus Holdings, Inc. vs BioCryst Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Veracyte, Inc. vs MannKind Corporation
Comparing Innovation Spending: Veracyte, Inc. and Ligand Pharmaceuticals Incorporated